Groothuis PG - Search Results

1

TP53 overexpression in recurrent endometrial carcinoma.

Pijnenborg JM, van de Broek L, Dam de Veen GC, Roemen GM, de Haan J, van Engeland M, Voncken JW, Groothuis PG. Pijnenborg JM, et al. Among authors: groothuis pg. Gynecol Oncol. 2006 Feb;100(2):397-404. doi: 10.1016/j.ygyno.2005.09.056. Epub 2005 Nov 4. Gynecol Oncol. 2006. PMID: 16271749

2

APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.

Pijnenborg JM, Kisters N, van Engeland M, Dunselman GA, de Haan J, de Goeij AF, Groothuis PG. Pijnenborg JM, et al. Among authors: groothuis pg. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):947-56. doi: 10.1111/j.1048-891X.2004.014534.x. Int J Gynecol Cancer. 2004. PMID: 15361208

3

Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma.

Pijnenborg JM, Romano A, Dam-de Veen GC, Dunselman GA, Fischer DC, Groothuis PG, Kieback DG. Pijnenborg JM, et al. Among authors: groothuis pg. J Pathol. 2005 Apr;205(5):597-605. doi: 10.1002/path.1738. J Pathol. 2005. PMID: 15726651

4

RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.

Pijnenborg JM, Dam-de Veen GC, Kisters N, Delvoux B, van Engeland M, Herman JG, Groothuis PG. Pijnenborg JM, et al. Among authors: groothuis pg. Ann Oncol. 2007 Mar;18(3):491-7. doi: 10.1093/annonc/mdl455. Epub 2006 Dec 14. Ann Oncol. 2007. PMID: 17170014 Free article.

5

Hypoxia contributes to development of recurrent endometrial carcinoma.

Pijnenborg JM, Wijnakker M, Hagelstein J, Delvoux B, Groothuis PG. Pijnenborg JM, et al. Among authors: groothuis pg. Int J Gynecol Cancer. 2007 Jul-Aug;17(4):897-904. doi: 10.1111/j.1525-1438.2007.00893.x. Epub 2007 Mar 13. Int J Gynecol Cancer. 2007. PMID: 17359291

6

Defective mismatch repair and the development of recurrent endometrial carcinoma.

Pijnenborg JM, Dam-de Veen GC, de Haan J, van Engeland M, Groothuis PG. Pijnenborg JM, et al. Among authors: groothuis pg. Gynecol Oncol. 2004 Aug;94(2):550-9. doi: 10.1016/j.ygyno.2004.05.020. Gynecol Oncol. 2004. PMID: 15297202

7

Inhibition of endometrial peritoneal attachment in the prevention and treatment of endometriosis.

Groothuis PG, Dunselman GA. Groothuis PG, et al. Gynecol Obstet Invest. 2004;57(1):52-3. doi: 10.1159/000297645. Gynecol Obstet Invest. 2004. PMID: 14974459 No abstract available.

8

Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.

Dassen H, Punyadeera C, Delvoux B, Schulkens I, Marchetti C, Kamps R, Klomp J, Dijcks F, de Goeij A, D'Hooghe T, Kyama C, Ederveen A, Dunselman G, Groothuis P, Romano A. Dassen H, et al. Am J Pathol. 2010 Nov;177(5):2495-508. doi: 10.2353/ajpath.2010.100026. Am J Pathol. 2010. PMID: 21048224 Free PMC article.

9

Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane.

Maas JW, Groothuis PG, Dunselman GA, de Goeij AF, Struijker-Boudier HA, Evers JL. Maas JW, et al. Among authors: groothuis pg. Hum Reprod. 2001 Apr;16(4):627-31. doi: 10.1093/humrep/16.4.627. Hum Reprod. 2001. PMID: 11278208

10

Etiology of endometriosis: hypotheses and facts.

Dunselman GA, Groothuis PG. Dunselman GA, et al. Among authors: groothuis pg. Gynecol Obstet Invest. 2004;57(1):42-3. Gynecol Obstet Invest. 2004. PMID: 14974453 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page